US 11,834,547 B2
Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use
Brian Aitken, Jacksonville, FL (US); Charles Scales, St. Augustine, FL (US); Scott Joslin, Ponte Vedra Beach, FL (US); Yong Zhang, Jacksonville, FL (US); Dola Sinha, Jacksonville, FL (US); Shivkumar Mahadevan, Jacksonville, FL (US); Patricia Martin, Jacksonville, FL (US); Fang Lu, St. Augustine, FL (US); Donnie Duis, Jacksonville, FL (US); and Stephen C. Arnold, Jacksonville, FL (US)
Assigned to Johnson & Johnson Vision Care, Inc., Jacksonville, FL (US)
Filed by Johnson & Johnson Vision Care, Inc., Jacksonville, FL (US)
Filed on Feb. 25, 2021, as Appl. No. 17/184,716.
Application 17/184,716 is a continuation of application No. 16/239,595, filed on Jan. 4, 2019, granted, now 10,961,341.
Claims priority of provisional application 62/623,781, filed on Jan. 30, 2018.
Prior Publication US 2021/0179766 A1, Jun. 17, 2021
Int. Cl. C08K 5/53 (2006.01); C08G 18/61 (2006.01); G02B 1/04 (2006.01); C08G 18/04 (2006.01); C08G 18/62 (2006.01); B29D 11/00 (2006.01); C08L 51/08 (2006.01); G02C 7/04 (2006.01); C08F 290/06 (2006.01)
CPC C08G 18/61 (2013.01) [B29D 11/00067 (2013.01); B29D 11/00076 (2013.01); C08F 290/068 (2013.01); C08G 18/04 (2013.01); C08G 18/6225 (2013.01); C08K 5/53 (2013.01); C08L 51/085 (2013.01); G02B 1/043 (2013.01); G02C 7/049 (2013.01); C08G 2270/00 (2013.01)] 11 Claims
 
1. An ophthalmic device comprised of a reaction product of a composition comprising:
(i) a crosslinked substrate network containing covalently bound monoacylphosphine oxide activatable free radical initiators; and
(ii) a grafting composition containing one or more ethylenically unsaturated compounds.